Determinants of Neutralizing Antibody Response After SARS CoV-2 Vaccination in Patients With Myeloma

Abstract

These data show that vaccine-induced antibodies in several patients with MM lack detectable virus-neutralizing activity. Vaccine-mediated induction of nAbs is affected by race, disease, vaccine, and treatment characteristics. These data have several implications for the emerging application of booster vaccines in immunocompromised hosts.